Medica 2010 - November 17-20, 2010, Düsseldorf, Germany
West Nile Detect™ IgM Capture ELISA
FDA Cleared - For in vitro diagnostic use
The complete kit includes 96 well strippable plate with all necessary reagents and controls.
InBios' West Nile Detect™ IgM Capture ELISA is for the qualitative presumptive detection of IgM antibodies to WNV recombinant antigens (WNRA) in serum as an aid in the clinical laboratory diagnosis of West Nile virus infection in patients with clinical symptoms consistent with encephalitis/meningitis. Positive results must be confirmed by Plaque Reduction Neutralization Test (PRNT), or by using the current CDC guidelines for diagnosis of this disease.
Features and Benefits
- Sensitivity and specificity > 95%.
- Easy to follow protocol.
- Results in 4 hours or less.
- Excellent correlation with PRNT and CDC ELISA
West Nile Detect™ Package Insert
References
Anderson BL, Litwin CM, and Welch RJ. Evaluation of a New Commercial Enzyme Immunoassay for the Detection of IgM Antibodies to
Ordering Information
Catalog Number: WNMS-1